The Nordic Diagnostic Industry Stakeholders Network

Central areas

DiagISN The Nordic Diagnostic Industry Stakeholders Network started in January 2006 and continued until December 2007.

The focus for DiagISN was to build a network of companies and selected non-commercial competence centres around issues of a high importance for Diagnostics Industry and in establishing diagnostic tools for pharmaceutical R&D. Among the key ambitions of DiagISN was to interact with development of pharmaceuticals, Biomarkers and Efficacy, the Innovative Medicines Initiative, FDAs draft to Drug-Diagnostics Co-Development concept paper are all examples of important areas that will be discussed.

Activities

History of DiagISN

Organisational set-up

Members

Home